Both in R&D — Physical & Biological Sciences
Incyte Genomics vs IQVIA Holdings
Over the past year INCY returned +11.6% and IQV returned +26.1%; their daily moves had a correlation of 0.38.
INCY +11.6% IQV +26.1%Growth of $1, one year, split-adjusted
| Metric | INCY | IQV |
|---|---|---|
| Price | $118.01 | $264.88 |
| Market cap | $24.05B | $43.65B |
| Today | −3.94% | +0.41% |
| 1 month | +4.0% | +2.6% |
| 6 months | +20.7% | +48.3% |
| Year to date | +19.5% | +17.5% |
| 1 year | +14.7% | +25.6% |
| Revenue growth (YoY) | +14.0% | +8.0% |
| Gross margin | 93.0% | 33.8% |
| Net margin | −50.4% | 7.9% |
| P/E (TTM) | 59.6× | 31.3× |
| Price / sales | 4.0× | 2.5× |
| Net cash | $3.82B | -$13.64B |
| Dividend yield | — | — |
| Volatility (60d) | 29.8% | 26.7% |
| Short % of float | 5.9% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).